BRP Inc.

DOO

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

# Signal Note: Driehaus Capital Initiates $40.7M Position in BRP Inc.

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 575,366Value: $40.7M

# Signal Note: Driehaus Capital Initiates $40.7M Position in BRP Inc. (DOO) Growth-focused Driehaus's entry into DOO (575k shares) signals conviction in the biotech's pipeline, likely driven by upcoming clinical catalysts or commercial validation. BRP's lead program, seribantumab (MM-121), targets HER2-mutant non-small cell lung cancer—a precision oncology niche with limited competition and potential near-term readouts that could de-risk the valuation. The timing suggests positioning ahead of anticipated Phase II/III data or regulatory milestones in 2024-2025.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: